AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor.

The central melanocortin (MC) system has been demonstrated to act downstream of leptin in the regulation of body weight. The system comprises alpha-MSH, which acts as agonist, and agouti-related protein (AgRP), which acts as antagonist at the MC3 and MC4 receptors (MC3R and MC4R). This property suggests that MCR activity is tightly regulated and that opposing signals are integrated at the receptor level. We here propose another level of regulation within the melanocortin system by showing that the human (h) MC4R displays constitutive activity in vitro as assayed by adenylyl cyclase (AC) activity. Furthermore, human AgRP(83-132) acts as an inverse agonist for the hMC4R since it was able to suppress constitutive activity of the hMC4R both in intact B16/G4F melanoma cells and membrane preparations. The effect of AgRP(83-132) on the hMC4R was blocked by the MC4R ligand SHU9119. Also the hMC3R and the mouse(m)MC5R were shown to be constitutively active. AgRP(83-132) acted as an inverse agonist on the hMC3R but not on the mMC5R. Thus, AgRP is able to regulate MCR activity independently of alpha-MSH. These findings form a basis to further investigate the relevance of constitutive activity of the MC4R and of inverse agonism of AgRP for the regulation of body weight.

[1]  G. Barsh,et al.  The role of agouti-related protein in regulating body weight. , 1999, Molecular medicine today.

[2]  C. Mobbs,et al.  Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. , 1999, Endocrinology.

[3]  A. Eberle,et al.  B16‐G4F mouse melanoma cells: An MSH receptor‐deficient cell clone , 1993, FEBS letters.

[4]  M. Tota,et al.  ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. , 1997, Biochemical and biophysical research communications.

[5]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[6]  J. Burbach,et al.  Conformation of the Core Sequence in Melanocortin Peptides Directs Selectivity for the Melanocortin MC3 and MC4 Receptors* , 1999, The Journal of Biological Chemistry.

[7]  C. Priest,et al.  Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting and [corrected] in ob/ob and db/db mice, but is stimulated by leptin. , 1998, Diabetes.

[8]  J. Shutter,et al.  Overexpression of Agrt leads to obesity in transgenic mice , 1997, Nature Genetics.

[9]  G. Barsh,et al.  Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. , 1997, The Journal of investigative dermatology.

[10]  G. Barsh,et al.  Anatomy of an Endogenous Antagonist: Relationship between Agouti-Related Protein and Proopiomelanocortin in Brain , 1999, The Journal of Neuroscience.

[11]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[12]  Y. Salomon.  Adenylate cyclase assay. , 1979, Advances in cyclic nucleotide research.

[13]  S. Watson,et al.  Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. , 1993, The Journal of biological chemistry.

[14]  A. Thody,et al.  Agouti protein can act independently of melanocyte-stimulating hormone to inhibit melanogenesis. , 1995, The Journal of endocrinology.

[15]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[16]  S. Woods,et al.  Leptin Increases Hypothalamic Pro-opiomelanocortin mRNA Expression in the Rostral Arcuate Nucleus , 1997, Diabetes.

[17]  R. Cone,et al.  Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. , 1995, Journal of medicinal chemistry.

[18]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[19]  W. Wilkison,et al.  Agouti protein inhibits growth of B16 melanoma cells in vitro by acting through melanocortin receptors. , 1996, Biochemical and biophysical research communications.

[20]  W. Sadee,et al.  A synthetic human Agouti‐related protein‐(83–132)‐NH2 fragment is a potent inhibitor of melanocortin receptor function , 1998, FEBS letters.

[21]  G. Barsh,et al.  Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. , 1998, Genes & development.

[22]  G. Milligan,et al.  Inverse agonism: pharmacological curiosity or potential therapeutic strategy? , 1995, Trends in pharmacological sciences.

[23]  G. Barsh,et al.  The interaction of agouti signal protein and melanocyte stimulating hormone to regulate melanin formation in mammals. , 1996, Pigment cell research.

[24]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[25]  K. Clément,et al.  A frameshift mutation in human MC4R is associated with a dominant form of obesity , 1998, Nature Genetics.

[26]  R. Palmiter,et al.  Response of melanocortin–4 receptor–deficient mice to anorectic and orexigenic peptides , 1999, Nature Genetics.

[27]  S. Watson,et al.  Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.

[28]  W. Wilkison,et al.  Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti. , 1997, Journal of receptor and signal transduction research.

[29]  健 海老原.  Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action , 2000 .

[30]  R. Leurs,et al.  Modulation of forskolin‐mediated adenylyl cyclase activation by constitutively active Gs‐coupled receptors , 1997, FEBS letters.

[31]  G. Barsh,et al.  Physiological and anatomical circuitry between Agouti-related protein and leptin signaling. , 1999, Endocrinology.

[32]  G. Barsh,et al.  Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. , 1993, Genes & development.

[33]  Helen L. Yin,et al.  The Actin Cytoskeleton Is Required for Receptor-mediated Endocytosis in Mammalian Cells* , 1997, The Journal of Biological Chemistry.

[34]  V. Katta,et al.  Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related protein. , 1998, Biochemistry.

[35]  Michael W. Schwartz,et al.  Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons , 1998, Nature Neuroscience.

[36]  G. Barsh,et al.  Characterization of Agouti-related protein binding to melanocortin receptors. , 1999, Molecular endocrinology.

[37]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[38]  K. Wakamatsu,et al.  Agouti protein inhibits the production of eumelanin and phaeomelanin in the presence and absence of alpha-melanocyte stimulating hormone. , 1997, Pigment cell research.

[39]  C. Priest,et al.  Hypothalamic Pro-Opiomelanocortin mRNA Is Reduced By Fasting in ob/ob and db/db Mice, but Is Stimulated by Leptin , 1998, Diabetes.

[40]  Y. Konda,et al.  Molecular cloning, expression, and characterization of a fifth melanocortin receptor. , 1994, Biochemical and biophysical research communications.

[41]  G. Barsh,et al.  Modulation of murine melanocyte function in vitro by agouti signal protein , 1997, The EMBO journal.

[42]  J. Hebebrand,et al.  Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. , 1999, American journal of human genetics.

[43]  R. Woychik,et al.  Molecular characterization of the mouse agouti locus , 1992, Cell.

[44]  S. O’Rahilly,et al.  A frameshift mutation in MC4R associated with dominantly inherited human obesity , 1998, Nature Genetics.

[45]  S. Bloom,et al.  A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. , 1998, Endocrinology.

[46]  P. Prusis,et al.  Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist , 1999, British journal of pharmacology.